마드리드 유럽 류머티즘 회의EULAR 2017European League Against Rheumatism Annual European Congress of Rheumatology
마드리드 유럽 류머티즘 회의 Official Site
EULAR 2017
European League Against Rheumatism Annual European Congress of Rheumatology
장소 : Spain(스페인) / Madrid(마드리드)
기간 : 2017년 06월 14일 ~ 2017년 06월 17일

박람회장 인근 호텔 보기

호텔가격비교예약
항공권비교예약
렌터카가격비교
공항미팅서비스
현지투어예약
유레일예약
여행자보험
어떻게다닐까?
견적/문의/신청하기
문의내용
한국출발 현지출발
출발지
일정
참가 / / (*어린이: 출발일 연령이 2세 이상 12세 미만 *유아: 출발일 연령이 2세 미만)
희망호텔 클래스 객실유형
희망항공사 출발시간
추가서비스 선택
신청자성명(한글) 신청자성명(여권영문)
성별
회사명
부서 업종
회사전화번호 핸드폰
이메일 카카오톡ID
동행자

동행자추가 동행자삭제

문의사항

보내기

마드리드 유럽 류머티즘 회의
EULAR 2017
European League Against Rheumatism Annual European Congress of Rheumatology Official Site
개최기간 2017년 06월 14일 ~ 2017년 06월 17일 개최국/도시 Spain (스페인) / Madrid (마드리드)
Frequency 1년 1회 Venue Feria de Madrid -IFEMA
분류 혈액학 관절염·류마티스
주요출전품

 

 

The next EULAR Annual European Congress of Rheumatology will take place between the 14 and 17 June 2017 in Madrid, Spain. The annual EULAR Congress continues to be a major event in the calendar of world rheumatology, and Madrid 2017 will again provide a unique event for the exchange of scientific and clinical information. It will be a platform to facilitate interactions between patients, medical doctors, scientists, health professionals, and professionals representing the pharmaceutical industry both from within Europe and from around the world. In addition, we will also see the first results of our new initiatives regarding the EULAR School of Rheumatology, the EULAR Campaign and the       EULAR Research Roadmap "RheumaMap".

EULAR Congresses have received tremendous interest in terms of participation and quality of contributions. This also reflects the availability of increased information on the impact, burden and cost of these diseases for society, and a significantly improved ability to diagnose and treat them. The incorporation of health professional and patient organisations within EULAR has been a considerable stimulus for these advances. This integration will facilitate the implementation of recommendations for management/standards of care of musculoskeletal disorders in daily practice of which we have seen prime examples in the London EULAR Congress.

The EULAR Congress 2017 in Madrid will once again offer a wide range of topics including clinical innovations, clinical translational and basic science. In addition, there will be meetings organised by People with Arthritis and Rheumatism in Europe (PARE), by Health Professionals in Rheumatology (HPR) and by the health care industry. The central activity of the congress will be poster presentations and poster tours with their highly interactive exchanges among participants. The Madrid event will further strengthen the reputation of the EULAR Congress as a highly innovative and informative venue for clinical and translational researchers not only within the different facets of our discipline (e.g., inflammation, pain, bone, mechanical and inflammatory disorders). The Madrid meeting will further promote the reputation of the EULAR Congress as a most innovative and informative venue for clinical research for the practising physician. In addition, the EULAR EMEUNET organisation of young rheumatologists will also attract young colleagues to the meeting and will disseminate the message that rheumatology is one of the most attractive and successful disciplines of medicine.

We are very happy to visit the city of Madrid for the second time. In 2013 we were impressed by the magnificent ambiance of astonishing architecture, galleries, museums, theatres and culinary pleasures – and as a football fan I must add sports events - under Southern skies. Thus, Madrid will again provide an excellent background for scientific and clinical exchanges, international collaborations and renewal of friendships. We will take great pleasure in welcoming medical doctors, patients, health professionals and representatives of the pharmaceutical industry to EULAR 2017, and hope that their stay in Madrid will be informative, educational and, last but not least, enjoyable.

 

 

About EULAR

The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. EULAR endeavours to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. In line with UEMS, EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems.

 

Congress mission statement

The aim is to provide a forum of the highest standard for scientific (both clinical and basic), educational and social exchange between professionals involved in rheumatology, liaising with patient organisations, in order to achieve progress in the clinical care of people with RMDs.

 

Scientific Programme

 

The scientific programme will start on Wednesday, 14 June 2017 at 13:00 and will finish on Saturday, 17 June 2017 at 15:00. The congress will cover the broad spectrum of the rheumatic diseases and include state-of-the-art lectures, basic science and clinical symposia, abstract sessions, presentations and discussions of difficult cases, workshops and special interest group sessions. Abstracts can be submitted on the following topics (for instructions, see “Abstract Information” in this programme on pages 11-13). Sessions of the Health Professionals in Rheumatology and of EULAR PARE (People with Arthritis/Rheumatism in Europe) will extend and complement the programme on all days

 

 

BASIC AND TRANSLATIONAL RESEARCH
01. Genomics, genetic basis of disease and HLA/T cell recognition
02. Adaptive immunity (T cells and B cells) in rheumatic diseases
03. Innate immunity in rheumatic diseases
04. Cytokines and inflammatory mediators
05. Cartilage, synovium and osteoimmunology
06. Rheumatoid arthritis - etiology, pathogenesis and animal models
07. Spondyloarthritis - etiology, pathogenesis and animal models
08. SLE, Sjögren’s and APS - etiology, pathogenesis and animal
models
09. Scleroderma, myosotis and related syndromes -
etiology, pathogenesis and animal models
10. Basic science in paediatric rheumatology

 

CLINICAL TOPICS BY DISEASE
11. Rheumatoid arthritis - prognosis, predictors and outcome
12. Rheumatoid arthritis - comorbidity and clinical aspects
13. Rheumatoid arthritis - anti-TNF therapy
14. Rheumatoid arthritis - other biologic treatment
15. Rheumatoid arthritis - non biologic treatment
16. SLE, Sjögren’s and APS - treatment
17. SLE, Sjögren’s and APS - clinical aspects (other than treatment)
18. Vasculitis
19. Scleroderma, myositis and related syndromes
20. Spondylarthropathies - treatment
21. Spondylarthropathies - clinical aspects (other than treatment)
22. Psoriatic arthritis
23. Osteoarthritis
24. Osteoporosis
25. Crystal diseases, metabolic bone diseases other than
osteoporosis
26. Infection-related rheumatic diseases
27. Fibromyalgia
28. Back pain, mechanical musculoskeletal problems, local soft
tissue disorders
29. Paediatric rheumatology
30. Other orphan diseases

 

CLINICAL TOPICS BY AREA OF RESEARCH
31. Diagnostics and imaging procedures
32. Public health, health services research, and health economics
33. Epidemiology, risk factors for disease or disease progression
34. Validation of outcome measures and biomarkers
35. Rehabilitation
36. Education